1. Home
  2. INAB vs HYFM Comparison

INAB vs HYFM Comparison

Compare INAB & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • HYFM
  • Stock Information
  • Founded
  • INAB 2016
  • HYFM 1977
  • Country
  • INAB United States
  • HYFM United States
  • Employees
  • INAB N/A
  • HYFM N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • HYFM Industrial Machinery/Components
  • Sector
  • INAB Health Care
  • HYFM Industrials
  • Exchange
  • INAB Nasdaq
  • HYFM Nasdaq
  • Market Cap
  • INAB 14.5M
  • HYFM 17.1M
  • IPO Year
  • INAB 2021
  • HYFM 2020
  • Fundamental
  • Price
  • INAB $2.49
  • HYFM $3.64
  • Analyst Decision
  • INAB Strong Buy
  • HYFM Hold
  • Analyst Count
  • INAB 2
  • HYFM 2
  • Target Price
  • INAB $108.00
  • HYFM $7.00
  • AVG Volume (30 Days)
  • INAB 185.2K
  • HYFM 8.4K
  • Earning Date
  • INAB 08-07-2025
  • HYFM 08-07-2025
  • Dividend Yield
  • INAB N/A
  • HYFM N/A
  • EPS Growth
  • INAB N/A
  • HYFM N/A
  • EPS
  • INAB N/A
  • HYFM N/A
  • Revenue
  • INAB N/A
  • HYFM $176,650,000.00
  • Revenue This Year
  • INAB N/A
  • HYFM $5.45
  • Revenue Next Year
  • INAB N/A
  • HYFM $5.33
  • P/E Ratio
  • INAB N/A
  • HYFM N/A
  • Revenue Growth
  • INAB N/A
  • HYFM N/A
  • 52 Week Low
  • INAB $2.05
  • HYFM $1.50
  • 52 Week High
  • INAB $27.30
  • HYFM $8.55
  • Technical
  • Relative Strength Index (RSI)
  • INAB 44.14
  • HYFM 50.82
  • Support Level
  • INAB $2.10
  • HYFM $3.51
  • Resistance Level
  • INAB $2.30
  • HYFM $3.94
  • Average True Range (ATR)
  • INAB 0.13
  • HYFM 0.28
  • MACD
  • INAB 0.10
  • HYFM -0.02
  • Stochastic Oscillator
  • INAB 96.70
  • HYFM 48.39

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.

Share on Social Networks: